EUVIMED · CrossrefJournal
Clinical Cancer Research
ISSN 1078-0432 · American Association for Cancer Research (AACR)
Latest articles
A randomised phase II trial of neoadjuvant chemotherapy with or without concurrent aromatase inhibitor therapy in ER-positive breast cancer (ANZ1401 ELIMINATE)
The first-in-class SFK ‘OFF’ inhibitor NXP900 suppresses YAP signaling and demonstrates tumor growth suppression in cholangiocarcinoma
Serplulimab combined with nab-paclitaxel and epirubicin in high-risk, early HR+/HER2- breast cancer (HELEN-B 018): a multicentre, single-arm, phase 2 trial
GnRH-a Plus Letrozole vs Ethinylestradiol/Cyproterone Acetate Plus Metformin in Progestin-Insensitive Endometrial Atypical Hyperplasia: A Multicenter Phase II RCT
Molecularly profiling cell-free DNA from cerebrospinal fluid yields quantitative biomarkers to diagnose and monitor breast cancer leptomeningeal carcinomatosis
Molecular Residual Disease After Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer: Clinical Value and Optimal Timing for ctDNA Assessment.
Longitudinal Detection of Circulating Tumor DNA in Children with Pleuropulmonary Blastoma: A Report from the International PPB/DICER1 Registry
Genomic, Clinical, and Spatial Predictors of Durable Response to BRAF/MEK Inhibition in BRAF -Mutant Melanoma
Identification of Proteomic Subtypes with Differential Responses to Immune Checkpoint Inhibition in Cutaneous Melanoma
Molecular Features Underlying Discordance Between Clinical and Genomic Risk Stratification in Localized Prostate Cancer in Over 280, 000 Patients
Molecular determinants of antibody-mediated priming to enhance detection of ctDNA
CCNE1 Amplification Confers Poor Outcomes and Therapeutic Resistance in Breast Cancer
Spatial Immune Organization Associates with Response to CD40 Agonism in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer: A Phase I Trial
Molecular and Clinical Characteristics of Patients with Non–Small Cell Lung Cancer Harboring KRAS Q61 Mutations to Assess Therapeutic Responses
Correction: Efficacy and CNS Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multicenter Basket Trial Analysis (NCI/SWOG S1609)
Correction: Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination
Editor’s Note: Aspirin Suppresses the Growth and Metastasis of Osteosarcoma through the NF-κB Pathway
An Act of DeFianCe: Targeting DKK1 in Metastatic Colorectal Cancer
Second- and Third-Line Outcomes after Selective RET Inhibitor Failure in RET Fusion-Positive Metastatic Lung Cancer: A Real-World Analysis from the RET-MAP Registry
Location, Location, Location: Membranous Nectin-4 as a Biomarker for Enfortumab Vedotin
Dual VEGF and PD-(L)1 Blockade: Facts and Hopes
Targeting DHFR to suppress one-carbon metabolism and enhance radiation sensitivity in patients with NRF2-active head and neck squamous cell carcinoma
SPROUT Guidelines for Molecular Profiling for Children with Solid Tumors: A Consensus Recommendation from the American Association for Cancer Research
Anti-TNFR2 Antibody BI-1808 Induces Tumor Regression and Antitumor T-cell Immunity through Treg and Myeloid Cell Modulation in Patients with Solid Tumors
Palbociclib, Fulvestrant, Trastuzumab, and Pyrotinib for Patients with Advanced Breast Cancer with Brain Metastases: A Prospective Multicenter Phase 2 Trial
Prevalence and Actionability of MTAP Loss in Driver Oncogene-Positive and Oncogene-Negative Lung Cancer
BRCA1 at the Crossroads of Genome Stability, Mitochondrial Homeostasis, and Tumor Immunity
Kinetics of Re-differentiation with Short-Course Dabrafenib and Trametinib in Patients with Radioiodine-Refractory Thyroid Cancer
Phase I Trial and Biomarker Analysis of Buparlisib with Weekly Cisplatin and Radiotherapy in High-risk Locally Advanced Squamous Cell Cancer of the Head and Neck
Impact of Dosage Modifications on Efficacy: Insights from Select Tyrosine Kinase Inhibitors Approved for Treatment of Non-Small Cell Lung Cancer with EGFR Mutations
EUVIMED